|
PicksThatMove: www.PicksThatMove.com: www.PicksThatMove.com: www.PicksThatMove.com Alerts, June 29, 2009: ADTN, SBUX, ARUN, SGMO, EPCT and MOT.
Jun 29, 2009 (M2 PRESSWIRE via COMTEX) --
Picksthatmove.com Alerts for Tuesday include ADTRAN(R), Inc., (NASDAQ: ADTN); Starbucks Coffee Company (NASDAQ: SBUX); Aruba Networks, Inc. (NASDAQ: ARUN); Sangamo BioSciences, Inc. (Nasdaq: SGMO); EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) and Motorola, Inc. (NYSE: MOT)
-- Jun 26, 2009 ADTRAN(R), Inc., (NASDAQ:ADTN) closed at $21.02 on a volume of 1,630,066 shares.
NTELOS Selects ADTRAN Total Access 5000 for Broadband DLC
IP Ethernet Core Enables Smooth Transition to Next-Generation Services
HUNTSVILLE, Ala., Jun 29, 2009 -- ADTRAN(R), Inc., (NASDAQ:ADTN), a leading provider of next-generation networking solutions, today announced that NTELOS, a leading provider of wireless and wireline communications to consumers and businesses in Virginia and West Virginia, has selected ADTRAN's flagship product, the Total Access(R) 5000 Multi-Service Access and Aggregation Platform (MSAP) for Broadband Digital Loop Carrier (BBDLC) applications. The implementation of the Total Access 5000, with its all-Ethernet core, will enable NTELOS to cost-effectively provide broadband data, IP video and voice services within its customer base.
Intevac Photonics: We are a leader in the development and manufacture of leading edge, high-sensitivity imaging products and vision systems, as well as table-top and handheld Raman instruments Markets addressed include military, law enforcement, industrial, physical science and life science.
About ADTRAN
ADTRAN, Inc. is a leading global provider of networking and communications equipment, with a portfolio of more than 1,700 solutions for use in the last mile of today's telecommunications networks. Widely deployed by carriers and enterprises alike, ADTRAN solutions enable voice, data, video, and Internet communications across copper, fiber, and wireless network infrastructures. ADTRAN solutions are currently in use by every major U.S. service provider and many global ones, as well as by thousands of public, private and governmental organizations worldwide.
-- Jun 26, 2009 Starbucks Coffee Company (NASDAQ:SBUX) closed at $14.53 on a volume of 14,921,084 shares.
Starbucks and Fairtrade Partner in Rwanda
Starbucks, Fairtrade organizations join in sustainable development efforts in Rwanda; new Rwanda Fairtrade Certified Coffee coming to UK Starbucks in 2010; business forum explores entrepreneurial spirit focusing on responsible capitalism
KIGALI, Rwanda, Jun 29, 2009 -- Starbucks Coffee Company (NASDAQ:SBUX) today announced the latest development in its relationship with Fairtrade following its announcement that all of its espresso will be both Starbucks(TM) Shared Planet(TM) and Fairtrade Certified(TM) in the UK by the end of this year. Starbucks will now also offer its first 100 percent Fairtrade Certified whole bean coffee from Rwanda, which will be available as a limited edition coffee across UK Starbucks stores beginning early 2010.
About Starbucks
Starbucks Coffee Company provides an uplifting experience that enriches people's lives one moment, one human being, one extraordinary cup of coffee at a time. To share in the experience, visit www.starbucks.com.
-- Jun 26, 2009 Aruba Networks, Inc. (NASDAQ: ARUN) closed at $8.68 on a volume of 3,296,705 shares.
Virginia Union University Retrofits Its Richmond Campus With a High Performance 802.11n Wi-Fi Network From Aruba Networks
University Replaces Aging Proxim Network With New High-Speed 802.11n Network, Policy-Enforcement Firewall, Guest Access System, and AirWave Wireless Management Suite
SUNNYVALE, CA, Jun 29, 2009 -- Aruba Networks, Inc. (NASDAQ: ARUN), a global leader in wireless LANs and secure mobility solutions, today announced that Virginia Union University has deployed an Aruba 802.11n solution and AirWave Wireless Management Suite at its 84-acre campus in Richmond, Virginia. Founded in 1865 to give newly emancipated freedmen an opportunity for education and advancement, the university's network of independent Fat AP wireless access points lacked centralized management, and robust wireless performance. Prior to selecting a new wireless vendor the university staged a competitive evaluation between Aruba and two other vendors. Aruba's solution was determined to be both more economical and technically superior, and the university subsequently purchased an Aruba 802.11n Wi-Fi network and AirWave Wireless Management Suite.
About Aruba Networks
People move. Networks must follow. Aruba securely delivers networks to users, wherever they work or roam. Our mobility and network virtualization solutions ensure that the enterprise network moves in lock-step with users:
-- Adaptive 802.11n Wi-Fi networks optimize themselves to ensure that users are always within reach of mission-critical information; -- Identity-based security assigns access policies to users, enforcing those policies whenever and wherever a network is accessed; -- Remote networking solutions ensure uninterrupted access to enterprise resources without compromising security; -- Multi-vendor network management provides a single point of control while managing both legacy and new wireless networks from Aruba and its competitors.
-- Jun 26, 2009 Sangamo BioSciences, Inc. (Nasdaq: SGMO) closed at $4.93 on a volume of 1,062,758 shares.
Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech
RICHMOND, Calif., June 29, 2009 -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced that a key research milestone has been achieved in its Research and License Agreement with Genentech, Inc., a wholly-owned member of the Roche Group, for the generation of cell lines with novel characteristics for pharmaceutical protein production purposes using Sangamo's proprietary zinc finger DNA-binding protein nuclease (ZFN) technology. Genentech scientists demonstrated the successful knockout of two preselected genes in a Chinese hamster ovary (CHO) cell line. The milestone achievement triggered a payment from Genentech to Sangamo.
About Sangamo
Sangamo BioSciences, Inc. is focused on researching and developing zinc finger DNA-binding protein (ZFP) technology for therapeutic gene regulation and modification. By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TF(TM)) that can control gene expression and, consequently, cell function. Sangamo is also developing sequence-specific ZFP Nucleases (ZFN(TM)) for gene modification. The most advanced ZFP Therapeutic(TM) development program is currently in Phase 2 clinical trials for evaluation of safety and clinical effect in patients with diabetic neuropathy and ALS. Sangamo also has a Phase 1 clinical trial to evaluate safety and clinical effect of a ZFP Therapeutic for the treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo has established strategic partnerships with companies in non-therapeutic applications of its ZFP Technology, including Dow AgroSciences, Sigma-Aldrich Corporation Genentech and Pfizer. For more information about Sangamo and the ZFP Technology, visit www.sangamo.com.
-- Jun 26, 2009 EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) closed at $0.76 on a volume of 236,343 shares.
EpiCept Shares on the OMX Nordic Exchange Transferred Back to Ordinary Position from Observation Segment
TARRYTOWN, N.Y., Jun 29, 2009 -- Regulatory News: EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that its common stock traded on the OMX Nordic Exchange in Stockholm has been removed from the observation segment and transferred back to its ordinary position on the Exchange as of today, June, 29, 2009.
About EpiCept Corporation
EpiCept is focused on the development and commercialization of pharmaceutical products for the treatment of cancer and pain. The Company's lead product is Ceplene(R), which has been granted full marketing authorization by the European Commission for the remission maintenance and prevention of relapse in adult patients with Acute Myeloid Leukemia in first remission. The Company has two oncology drug candidates currently in clinical development that were discovered using in-house technology and have been shown to act as vascular disruption agents in a variety of solid tumors. The Company's pain portfolio includes EpiCept(TM) NP-1, a prescription topical analgesic cream in late-stage clinical development designed to provide effective long-term relief of pain associated with peripheral neuropathies.
-- Jun 26, 2009 Motorola, Inc. (NYSE: MOT) closed at $6.62 on a volume of 35,244,248 shares.
Motorola Study Shows Over Seven in Ten Manufacturers View Mobility as Key to Converting Downtime into Productive Time
Surveyed manufacturing IT decision-makers cite year-over-year increases in mobile solutions' importance
HOLTSVILLE, N.Y., June 29, 2009 -- A recent research study commissioned by Motorola, Inc. (NYSE: MOT) found over seven in ten surveyed Information Technology (IT) decision-makers in the manufacturing industry looking to leverage mobile and wireless solutions to streamline operations. The study found manufacturers with mobility applications saved a daily average of 42 minutes per employee.
About Motorola
Motorola is known around the world for innovation in communications and is focused on advancing the way the world connects. From broadband communications infrastructure, enterprise mobility and public safety solutions to high-definition video and mobile devices, Motorola is leading the next wave of innovations that enable people, enterprises and governments to be more connected and more mobile. Motorola (NYSE: MOT) had sales of US $30.1 billion in 2008. For more information, please visit www.motorola.com.
About PicksThatMove.com
www.picksthatmove.com team of excellence strives to find undervalued, good momentum stock plays. We provide financial and investor relations services for small to mid-cap stocks with weekly and special newsletters to keep you informed of the latest movers. Unlike other sites, we explore, research, and understand all aspects of a company. We only recommend companies we feel has the potential for future higher valuations. Our seasoned research team is always looking for the next Xtreme Pick to send to you.
www.picksthatmove.com is a leading stock website that provides free daily alerts on stocks that are moving up. www.picksthatmove.com also tracks small cap stocks that are on the brink of exploding. We also feature companies on our website with research report, analysis, and newsletters. To feature a company on our web site please contact us at Info@picksthatmove.com
www.picksthatmove.com is an independent electronic publication that provides information on selected publicly traded companies. www.picksthatmove.com is not a registered investment advisor or broker-dealer. www.picksthatmove.com affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.
CONTACT: e-mail: Info@picksthatmove.com
WWW: http://www.picksthatmove.com
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
[ InfoTech Spotlight's Homepage ]
|
